MediChem Life Sciences Announces Extension of Collaboration With Bristol-Myers Squibb Copmpany
MediChem Life Sciences (NASDAQ: MCLS), a Chicago-based drug discovery technology and services company, today announced that it has renewed its collaboration with Bristol Myers Squibb Company (NYSE: BMY), a pharmaceutical and related health care products company.
MediChem’s medicinal chemistry scientists will use its BLOCKbuilder™ program to provide Bristol-Myers Squibb’s parallel synthesis teams in Wallingford, Conn., and Princeton, N.J., with unique building blocks, monomers and scaffolds. Financial terms of the collaboration were not disclosed.
MediChem developed its BLOCKbuilder™ program for the efficient synthesis of multi-gram quantities of unique building blocks, monomers and scaffolds. MediChem designs and synthesizes building blocks for its clients’ parallel synthesis groups to speed up their drug discovery efforts.
"Our BLOCKbuilder™ program helps our clients break through bottlenecks," said Michael T. Flavin, Ph.D., president and CEO of MediChem. "With gram quantities of the right synthetic building blocks in hand, our clients’ parallel synthesis programs move more quickly."
"The MediChem collaboration has accelerated our efforts to expand and further diversify our compound deck," said Edward Petrillo, Ph.D., vice president, lead discovery and early discovery chemistry at Bristol-Myers Squibb. "We have had great results during the first year of the collaboration and we look forward to continuing the relationship."
Other news from the department business & finance
These products might interest you
Milli-Q® Services / MyMilli-Q™ by Merck Life Science
Services & Support for Water Purification Systems
Quality Care, Delivered. In Person & Online
Good Weighing Practice by Mettler-Toledo
Your Concrete Weighing Quality Assurance Plan
GWP Verification service
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
